Sequential vs upfront intensified neoadjuvant chemotherapy in patients with large resectable and/or locally advanced breast cancer. The INTENS Study.
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2017
At a glance
- Drugs Cyclophosphamide (Primary) ; Docetaxel (Primary) ; Doxorubicin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms INTENS
- 10 Jun 2017 Biomarkers information updated
- 10 Jul 2013 Primary endpoint 'Complete-pathological-response-rate' has not been met.
- 10 Jul 2013 Results published in the European Journal of Cancer.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History